HASHIDA H, Takabayashi A, Adachi M, et al.
The novel monoclonal
antibody MH8-4 inhibiting cell motility recognizes integrin alpha3: inverse of
its expression with metastases
in colon cancer.
Int J Oncol
2001;18:89-95.
Abstract:
http://www.amedeo.com/lit.cfm?uid=A11115543&aid=B120234&dopt=r&s=crnKATSUMATA
K, Sumi T, Yamashita S, et al.
The significance of thymidine phosphorylase
expression in colorectal cancer.
Oncol Rep 2001;8:127-130.
Abstract:
http://www.amedeo.com/lit.cfm?uid=A11115583&aid=B120234&dopt=r&s=crnSCHIMANSKI
CC, Linnemann U, Arbogast R, Berger MR.
Extended staging results from the
detection of isolated tumor cells in the liver of colorectal cancer
patients.
Oncol Rep 2001;8:185-188.
Abstract:
http://www.amedeo.com/lit.cfm?uid=A11115595&aid=B120234&dopt=r&s=crnTAYLOR
MT, Lawson KR, Ignatenko NA, et al.
Sulindac sulfone inhibits K-ras-dependent
cyclooxygenase-2 expression in human colon cancer cells.
Cancer Res
2000;60:6607-10.
Abstract:
http://www.amedeo.com/lit.cfm?uid=A11118042&aid=B120234&dopt=r&s=crnKIEVIT
E, Nyati MK, Ng E, et al.
Yeast cytosine deaminase improves
radiosensitization and bystander effect by 5-fluorocytosine of human colorectal
cancer xenografts.
Cancer Res 2000;60:6649-55.
Abstract:
http://www.amedeo.com/lit.cfm?uid=A11118048&aid=B120234&dopt=r&s=crnADRIS
S, Chuluyan E, Bravo A, et al.
Mice vaccination with interleukin
12-transduced colon cancer cells potentiates rejection of syngeneic
non-organ-related tumor cells.
Cancer Res 2000;60:6696-703.
Abstract:
http://www.amedeo.com/lit.cfm?uid=A11118055&aid=B120234&dopt=r&s=crnLLANEZA
A, Vizoso F, Rodriguez JC, et al.
Hyaluronic acid as prognostic marker in
resectable colorectal cancer.
Br J Surg 2000;87:1690-6.
Abstract:
http://www.amedeo.com/lit.cfm?uid=A11122186&aid=B120234&dopt=r&s=crn
